CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,000 | -70.0% | 15,001 | -29.5% | 0.00% | -100.0% |
| Q3 2018 | $10,000 | -16.7% | 21,293 | -10.4% | 0.00% | 0.0% |
| Q2 2018 | $12,000 | -55.6% | 23,761 | +106.3% | 0.00% | 0.0% |
| Q1 2018 | $27,000 | -73.0% | 11,516 | -67.1% | 0.00% | -80.0% |
| Q3 2017 | $100,000 | -67.0% | 34,975 | +191.0% | 0.01% | -81.5% |
| Q2 2015 | $303,000 | – | 12,020 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |